看词语>英语词典>avidity翻译和用法

avidity

n.  渴望;欲望; (化学)活动性;亲合力

医学

BNC.39431 / COCA.37559

英英释义

noun

双语例句

  • AIM: To investigate the titer and avidity of serum immunoglobulin G ( IgG) antibody for surface antigens of Porphyromonas gingivalis ( P. gingivalis) in sera from patients with early-onset periodontitis ( EOP) and evaluate the interrelationship of the antibody titer and avidity.
    目的:检测早发性牙周炎患者血清抗牙龈卟啉菌脂多糖IgG抗体的滴度和亲和力,并探讨抗体滴度水平和亲和力之间的相关性。
  • Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease
    B型脑脊髓膜炎患者恢复过程中的孔蛋白A特异性抗体亲和力
  • It can develop avidity of SOD and eliminate free radicals;
    能提高SOD活性和清除自由基;
  • Detecting ANCA in the SLE patient may help to judge the avidity of this disease
    检测SLE患者的ANCA可能有助于判断该疾病的活动性
  • The man began to eat with avidity.
    那人贪婪地吃起来。
  • Here we show that the lack of protection was not due to alterations caused by formalin but instead to low antibody avidity for protective epitopes.
    我们却发现这并不是因为福尔马林的作用,而是由于抗体与保护性表位的亲和力降低。
  • Maternal herpes simplex virus antibody avidity and risk of neonatal herpes
    母亲单纯疱疹病毒抗体亲合力与新生儿疱疹风险
  • Objective To compare the avidity of antibodies for myeloperoxidase ( MPO) in sera from patients with propylthiouracil ( PTU) induced vasculitis and patients with microscopic polyangiitis ( MPA) and their clinical association was further analyzed.
    目的比较丙基硫氧嘧啶(PTU)相关性小血管炎和原发性小血管炎抗髓过氧化物酶(MPO)抗体亲和力的大小及其与临床表现的关系。
  • After TCR/ CD3 complex cross-linking MHC/ peptide, LFA-1, expressed on T cell increases a higher affinity and avidity for ICAM-1 rapidly. LFA-1 is a key molecule in formation of the immune synapse.
    T细胞表面LFA1对ICAM1的亲和力及亲合力在TCR/CD3交联MHC/抗原肽后迅速上调,并参与T细胞免疫突触的形成。
  • This review concentrates on drug-resistance mechanisms of taxanes that include drug target change, avidity change between drug-target interaction, decrease of cellular effective drug concentration, downstream cellular responses to a drug target molecular lesion, and cell cycle regulation-mediated drug resistance.
    该文作者就其耐药机制的研究进展,分别从药物靶点及靶点与药物的亲和力改变、细胞内有效药物浓度降低、药物靶分子下游效应信号途径异常、细胞周期调控等方面作如下综述。